1,2-Dichloroethane → N-[(5-Fluoro-4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-1-(1-methylethyl)-6-(4-pyridinyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxamide
반응식
[CH3:1][CH:2]([N:4]1[C:8]2[N:9]=[C:10]([C:16]3[CH:21]=[CH:20][N:19]=[CH:18][CH:17]=3)[CH:11]=[C:12]([C:13](O)=[O:14])[C:7]=2[CH:6]=[N:5]1)[CH3:3].Cl.[NH2:23][CH2:24][C:25]1[C:26](=[O:34])[NH:27][C:28]([CH3:33])=[C:29]([F:32])[C:30]=1[CH3:31].C(Cl)CCl.C1C=NC2N(O)N=NC=2C=1.CN1CCOCC1>CN(C=O)C.O>[F:32][C:29]1[C:30]([CH3:31])=[C:25]([CH2:24][NH:23][C:13]([C:12]2[C:7]3[CH:6]=[N:5][N:4]([CH:2]([CH3:3])[CH3:1])[C:8]=3[N:9]=[C:10]([C:16]3[CH:17]=[CH:18][N:19]=[CH:20][CH:21]=3)[CH:11]=2)=[O:14])[C:26](=[O:34])[NH:27][C:28]=1[CH3:33]참가 물질
반응물 5
생성물 1
시약·촉매·용매 2
실험 절차
A mixture of 1-(1-methylethyl)-6-(4-pyridinyl)-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid (169 mg, 0.60 mmol), 3-(aminomethyl)-5-fluoro-4,6-dimethyl-2(1H)-pyridinone hydrochloride (136 mg, 0.660 mmol), EDC (150 mg, 0.780 mmol), HOAT (106 mg, 0.780 mmol), and N-methylmorpholine (0.264 mL, 2.400 mmol) in DMF(3 mL) was stirred at room temperature for 3 days. water (15 mL) was added to the slurry, and it was stirred for an hour. The precipitate was then collected by vacuum filtration and rinsed with EtOH (4 mL), and the solid was dried in the vacuum oven overnight to give the title compound as 220 mg (76%). LCMS E-S (M+H)=435.0. 1H NMR (400 MHz, DMSO-d6) δ ppm 1.56 (d, 7 H), 2.18 (d, J=2.78 Hz, 3 H), 2.25 (d, J=2.02 Hz, 3 H), 4.45 (d, J=4.80 Hz, 2 H), 5.37 (spt, J=6.65 Hz, 1 H), 8.19-8.25 (m, 2 H), 8.29 (s, 1 H), 8.44 (s, 1 H), 8.74-8.81 (m, 2 H), 9.07 (t, J=4.80 Hz, 1 H), 11.66 (br. s., 1 H).
후처리
- stirringwas stirred for an hour
- filtrationThe precipitate was then collected by vacuum filtration
- washrinsed with EtOH (4 mL)
- customthe solid was dried in the vacuum oven overnight
출처 및 근거
- ORD 기록
- ord-65f0bd2e7c0140feb5d7840b0888359a
- 출처 데이터셋
- uspto-grants-2015_07
- 특허 번호
- US09073924B2
반응 노트
불러오는 중…